Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06596642
A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
This real-world study will assess the efficacy and safety of luspatercept treatment for β-thalassemia major in Taiwan as well as the impact on quality of life.
Official title: Taiwan β-Thalassemia Major Real-World Study for Luspatercept
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
61
Start Date
2024-08-21
Completion Date
2026-12-17
Last Updated
2025-06-04
Healthy Volunteers
No
Conditions
Interventions
DRUG
Luspatercept
As per product label
Locations (5)
Local Institution - 02
Kaohsiung City, Taiwan
Local Institution - 04
Tainan, Taiwan
Local Institution - 01
Taipei, Taiwan
Local Institution - 03
Taipei, Taiwan
Local Institution - 05
Taoyuan District, Taiwan